Physician profile
Thomas Bat
NPI 1831172410
$1,934.68
in general payments reported to CMS, 2019-2025
25 companies · $144 in 2025
The $144 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $269 · 2020: $142 · 2021: $554 · 2022: $373 · 2023: $149 · 2024: $303 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $596.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $596.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $524.79 | 2019-2025 | Freestyle Libre 3, Infinity |
| Novo Nordisk INC | $287.22 | 2020-2025 | Rybelsus, Ozempic, Wegovy |
| Boston Scientific Corporation | $233.29 | 2019-2025 | Varithena Administration Pack, General - Pain Management |
| Janssen Pharmaceuticals, INC | $168.59 | 2019-2022 | |
| Abbvie INC. | $102.78 | 2021-2025 | |
| Amgen INC. | $95.20 | 2019-2021 | |
| Lilly USA, LLC | $62.06 | 2021-2024 | Zepbound, Jardiance |
| Upsher-Smith Laboratories LLC | $44.51 | 2019-2021 | |
| Hologic Sales and Service, LLC | $42.75 | 2023 | Aptima |
| Amarin Pharma, INC. | $31.99 | 2019-2021 | |
| Inspire Medical Systems, INC. | $30.13 | 2024 | Inspire |
| Exact Sciences Corporation | $29.95 | 2025 | Cologuard Collection Kit |
| Pfizer INC. | $29.71 | 2019-2020 | |
| Astellas Pharma US INC | $28.96 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $26.79 | 2020-2023 | Trintellix |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $26.31 | 2024 | Farxiga |
| Edwards Lifesciences Corporation | $25.47 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Regeneron Healthcare Solutions, INC. | $23.75 | 2024 | Evkeeza |
| Bayer Healthcare Pharmaceuticals INC. | $21.27 | 2022 | |
| Allergan, INC. | $20.23 | 2020 | |
| Novartis Pharmaceuticals Corporation | $19.52 | 2024 | |
| Medtronic, INC. | $16.55 | 2023 | Venaseal |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.57 | 2021 | |
| Eisai INC. | $13.68 | 2021 | |
| Biogen, INC. | $13.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Bat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.